Skip to main navigation
Skip to search
Skip to main content
Johns Hopkins University Home
Search content at Johns Hopkins University
Home
Profiles
Research units
Research output
Anticancer activities of novel chalcone and bis-chalcone derivatives
Aneta Modzelewska
, Catherine Pettit
, Geetha Achanta
, Nancy E. Davidson
, Peng Huang
, Saeed R. Khan
Research output
:
Contribution to journal
›
Article
›
peer-review
321
Link opens in a new tab
Scopus citations
Overview
Fingerprint
Fingerprint
Dive into the research topics of 'Anticancer activities of novel chalcone and bis-chalcone derivatives'. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Keyphrases
Anticancer Activity
100%
Chalcone
100%
Chalcone Derivatives
100%
Bis-chalcones
100%
Human Breast Cancer Cell Line
66%
Estrogen Receptor-positive
33%
Estrogen Receptor-negative
33%
Epithelial Cell Line
33%
Wild-type p53
33%
Human Breast Cancer
33%
MCF-7
33%
Antitumor Activity
33%
MDA-MB-231
33%
Normal Breast
33%
Colon Cancer Cells
33%
Nanomolar Concentrations
33%
Breast Epithelial Cells
33%
MCF10A
33%
MCF-12A
33%
Isogenic Cell Lines
33%
Boronic Acid
33%
Medicine and Dentistry
Antineoplastic Activity
100%
Chalcone
100%
Chalcone Derivative
100%
Cell Line
66%
Estrogen Receptor
66%
Protein P53
66%
Breast Cancer Cell Line
66%
Breast Cancer
33%
Cancer Cell
33%
Epithelial Cell Line
33%
Colon Carcinoma
33%
Boronic Acid Derivative
33%
Pharmacology, Toxicology and Pharmaceutical Science
Breast Cancer
100%
Chalcone
100%
Chalcone Derivative
100%
Estrogen Receptor
66%
Protein P53
66%
Antitumor Activity
33%
Colon Carcinoma
33%
Boronic Acid Derivative
33%
Biochemistry, Genetics and Molecular Biology
Cancer Cell
100%
Antineoplastic Activity
100%
Estrogen Receptor
66%
P53
66%
Wild Type
33%
Colon
33%